Glaukos Corporation (GKOS) Financials

GKOS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 940.4 million 478.6 million
2023-09-30 948.6 million 471.0 million
2023-06-30 956.7 million 467.9 million
2023-03-31 972.6 million 464.1 million

GKOS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.9 million 13.0 million
2023-09-30 -11.5 million 10.5 million
2023-06-30 -13.9 million 9.9 million
2023-03-31 -37.7 million 10.2 million

GKOS Net Income

No data available :(

GKOS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 295.4 million - 101.0 million
2023-09-30 300.9 million - 101.4 million
2023-06-30 303.8 million - 101.8 million
2023-03-31 317.8 million - 101.5 million

GKOS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 48.9 million
2023-09-30 48.7 million
2023-06-30 48.3 million
2023-03-31 47.9 million

GKOS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4.2 million 39.1 million 63.0 million -
2023-09-30 3.4 million 33.3 million 54.2 million -
2023-06-30 5.8 million 36.2 million 53.1 million -
2023-03-31 6.9 million 35.2 million 53.7 million -

GKOS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 82.4 million 18.9 million
2023-09-30 78.0 million 18.5 million
2023-06-30 80.4 million 20.1 million
2023-03-31 73.9 million 18.1 million

GKOS

Price: $98.91

52 week price:
45.38
102.33

Earnings Per Share: -2.78 USD

P/E Ratio: -35.68

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Volume: 62314

Ebitda: 2.3 million

Market Capitalization: 5.0 billion

Links: